Phio Pharmaceuticals Corp. (PHIO) Tops Q3 EPS by 260c
Tweet
Share
E-mailGet Alerts PHIO Hot Sheet
Join SI Premium – FREE
Phio Pharmaceuticals Corp. (NASDAQ: PHIO) reported Q3 EPS of ($1.54), $2.60 better than the analyst estimate of ($4.14).
For earnings history and earnings-related data on Phio Pharmaceuticals Corp. (PHIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- Webull Corp (BULL) Tops Q2 EPS by 1c
- TJX stock drops as profit outlook falls short of analyst estimates
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
